Early Insight Into the Retrospective Data of a Case Series on Type 2 Diabetes Mellitus on Alternate-Day Dosing of Oral Semaglutide: Utopia or Reality?-Reference-Cited by-同舟云学术

Early Insight Into the Retrospective Data of a Case Series on Type 2 Diabetes Mellitus on Alternate-Day Dosing of Oral Semaglutide: Utopia or Reality?

Published:2023-04-03 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

RoyChaudhuri Soumyabrata,Majumder Anirban,Sanyal Debmalya,Chakraborty Soma,Chuyan Susama

Publisher

Springer Science and Business Media LLC

Subject

Aerospace Engineering

Reference35 articles.

1. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses;Nauck MA;J Clin Endocrinol Metab,1986

2. GIP and GLP-1, the two incretin hormones: similarities and differences;Seino Y;J Diabetes Investig,2010

3. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus;Meier JJ;Nat Rev Endocrinol,2012

4. Novel agents for the treatment of type 2 diabetes;DeFronzo RA;Diabetes Spectr,2014

5. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Davies MJ;Diabetes Care,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hot Water Eliminates the Bitter Taste of Oral Semaglutide: A Report of Four Cases;Internal Medicine;2024-08-15

2. Glycemic Control and the Weight Benefit of a Daily 7 mg Dose of Oral Semaglutide Versus an Alternate-Day 14 mg Dose of Oral Semaglutide From an Ambulatory Glucose Monitoring Data: A Retrospective Cohort Study From Eastern India;Cureus;2023-06-09